Stock Detail
EXACT SCIENCES CORPORATION
Biotechnology
EXAS @ Yahoo Finance | EXAS Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $8.29 | $8.84 | $0.11 | 1.34% | 0.00 | $8.18 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $8.04 | $8.04 | 1.68M | 438.79M | 619,479 | -18.84 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 9.19 | 8.74 | 8.39 | 7.94 | 7.59 |
Stock Profile
EXACT Sciences Corporation utilizes applied genomics to develop screening technologies for use in the detection of cancer. Certain of its technologies are offered in a commercial testing service, PreGen-Plus, developed by Laboratory Corporation of America Holdings. PreGen-Plus is a non-invasive stool-based DNA testing service for the detection of colorectal cancer in the average-risk population. EXACT Sciences was founded in 1995 and is headquartered in Marlborough, Massachusetts.